Acute hyperglycemia impairs functional improvement after spinal cord injury in mice and humans

Science Translational Medicine

Volumn 6, Issue 256, 2014, Pages

  Kobayakawa, Kazu ^a   Kumamaru, Hiromi ^a   Saiwai, Hirokazu ^a   Kubota, Kensuke ^a   Ohkawa, Yasuyuki ^a   Kishimoto, Junji ^b   Yokota, Kazuya ^a   Ideta, Ryosuke ^c   Shiba, Keiichiro ^c   Tozaki Saitoh, Hidetoshi ^b   Inoue, Kazuhide ^b   Iwamoto, Yukihide ^a   Okada, Seiji ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c SPINAL INJURIES CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN GLARGINE; TRANSCRIPTION FACTOR RELA;

AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FUNCTIONAL STATUS; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MICROGLIA; MOTOR DYSFUNCTION; MOUSE; NERVE INJURY; NONHUMAN; PROTEIN EXPRESSION; PROTEIN TRANSPORT; RISK FACTOR; SPINAL CORD INJURY; ACUTE DISEASE; ANIMAL; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ACUTE DISEASE; AGED; ANIMALS; APOPTOSIS; FEMALE; HUMANS; HYPERGLYCEMIA; MALE; MICE; MICROGLIA; NF-KAPPA B; PROTEIN TRANSPORT; SPINAL CORD INJURIES;

EID: 84908388448     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3009430     Document Type: Article

References (47)

1. M. M. Adams, A. L. Hicks, Spasticity after spinal cord injury. Spinal Cord 43, 577-586 (2005).
2. M. S. Beattie, Inflammation and apoptosis: Linked therapeutic targets in spinal cord injury. Trends Mol. Med. 10, 580-583 (2004).
3. H. Kumamaru, Y. Ohkawa, H. Saiwai, H. Yamada, K. Kubota, K. Kobayakawa, K. Akashi, H. Okano, Y. Iwamoto, S. Okada, Direct isolation and RNA-seq reveal environment-dependent properties of engrafted neural stem/progenitor cells. Nat. Commun. 3, 1140 (2012).
4. H. Kumamaru, H. Saiwai, Y. Ohkawa, H. Yamada, Y. Iwamoto, S. Okada, Age-related differences in cellular and molecular profiles of inflammatory responses after spinal cord injury. J. Cell. Physiol. 227, 1335-1346 (2012).
5. M. N. Hadley, B. C. Walters, P. A. Grabb, N. M. Oyesiku, G. J. Przybylski, D. K. Resnick, T. C. Ryken, D. H. Mielke, Guidelines for the management of acute cervical spine and spinal cord injuries. Clin. Neurosurg. 49, 407-498 (2002).
6. V. Failli, M. A. Kopp, C. Gericke, P. Martus, S. Klingbeil, B. Brommer, I. Laginha, Y. Chen, M. J. DeVivo, U. Dirnagl, J. M. Schwab, Functional neurological recovery after spinal cord injury is impaired in patients with infections. Brain 135, 3238-3250 (2012).
7. D. Davalos, J. Grutzendler, G. Yang, J. V. Kim, Y. Zuo, S. Jung, D. R. Littman, M. L. Dustin, W. B. Gan, ATP mediates rapid microglial response to local brain injury in vivo. Nat. Neurosci. 8, 752-758 (2005).
8. I. Pineau, S. Lacroix, Endogenous signals initiating inflammation in the injured nervous system. Glia 57, 351-361 (2009).
9. J. A. Ehses, A. Perren, E. Eppler, P. Ribaux, J. A. Pospisilik, R. Maor-Cahn, X. Gueripel, H. Ellingsgaard, M. K. Schneider, G. Biollaz, A. Fontana, M. Reinecke, F. Homo-Delarche, M. Y. Donath, Increased number of islet-associated macrophages in type 2 diabetes. Diabetes 56, 2356-2370 (2007).
10. C. L. Sherry, J. C. O'Connor, J. M. Kramer, G. G. Freund, Augmented lipopolysaccharide-induced TNF-α production by peritoneal macrophages in type 2 diabetic mice is dependent on elevated glucose and requires p38 MAPK. J. Immunol. 178, 663-670 (2007).
11. M. Tsuda, H. Ueno, A. Kataoka, H. Tozaki-Saitoh, K. Inoue, Activation of dorsal horn microglia contributes to diabetes-induced tactile allodynia via extracellular signal-regulated protein kinase signaling. Glia 56, 378-386 (2008).
12. M. A. Burguillos, T. Deierborg, E. Kavanagh, A. Persson, N. Hajji, A. Garcia-Quintanilla, J. Cano, P. Brundin, E. Englund, J. L. Venero, B. Joseph, Caspase signalling controls microglia activation and neurotoxicity. Nature 472, 319-324 (2011).
13. M. P. Habib, F. D. Dickerson, A. D. Mooradian, Effect of diabetes, insulin, and glucose load on lipid peroxidation in the rat. Metabolism 43, 1442-1445 (1994).
14. H. Saiwai, Y. Ohkawa, H. Yamada, H. Kumamaru, A. Harada, H. Okano, T. Yokomizo, Y. Iwamoto, S. Okada, The LTB4-BLT1 axis mediates neutrophil infiltration and secondary injury in experimental spinal cord injury. Am. J. Pathol. 176, 2352-2366 (2010).
15. P. P. Tak, G. S. Firestein, NF-κB: A key role in inflammatory diseases. J. Clin. Invest. 107, 7-11 (2001).
16. J. P. Thomas, A. W. Girotti, Glucose administration augments in vivo uptake and phototoxicity of the tumor-localizing fraction of hematoporphyrin derivative. Photochem. Photobiol. 49, 241-247 (1989).
17. Q. Cao, Y. P. Zhang, C. Iannotti, W. H. DeVries, X. M. Xu, C. B. Shields, S. R. Whittemore, Functional and electrophysiological changes after graded traumatic spinal cord injury in adult rat. Exp. Neurol. 191 (Suppl. 1), S3-S16 (2005).
18. American Diabetes Association, Standards of medical care in diabetes - 2009. Diabetes Care 32 (Suppl. 1), S13-S61 (2009).
19. R. P. Dellinger, M. M. Levy, J. M. Carlet, J. Bion, M. M. Parker, R. Jaeschke, K. Reinhart, D. C. Angus, C. Brun-Buisson, R. Beale, T. Calandra, J. F. Dhainaut, H. Gerlach, M. Harvey, J. J. Marini, J. Marshall, M. Ranieri, G. Ramsay, J. Sevransky, B. T. Thompson, S. Townsend, J. S. Vender, J. L. Zimmerman, J. L. Vincent, Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med. 34, 17-60 (2008).
20. J. T. Lucas, T. B. Ducker, Motor classification of spinal cord injuries with mobility, morbidity and recovery indices. Am. Surg. 45, 151-158 (1979).
21. D. P. Lammertse, L. A. Jones, S. B. Charlifue, S. C. Kirshblum, D. F. Apple, K. T. Ragnarsson, S. P. Falci, R. F. Heary, T. F. Choudhri, A. L. Jenkins, R. R. Betz, D. Poonian, J. P. Cuthbert, A. Jha, D. A. Snyder, N. Knoller, Autologous incubated macrophage therapy in acute, complete spinal cord injury: Results of the phase 2 randomized controlled multicenter trial. Spinal Cord 50, 661-671 (2012).
22. A. Catz, M. Itzkovich, E. Agranov, H. Ring, A. Tamir, SCIM - Spinal cord independence measure: A new disability scale for patients with spinal cord lesions. Spinal Cord 35, 850-856 (1997).
23. K. A. Gerhart, R. L. Johnson, J. Menconi, R. E. Hoffman, D. P. Lammertse, Utilization and effectiveness of methylprednisolone in a population-based sample of spinal cord injured persons. Paraplegia 33, 316-321 (1995).
24. B. Suberviola, A. González-Castro, J. Llorca, F. Ortiz-Melón, E. Miñambres, Early complications of high-dose methylprednisolone in acute spinal cord injury patients. Injury 39, 748-752 (2008).
25. A. S. Ibrahim, A. B. El-Remessy, S. Matragoon, W. Zhang, Y. Patel, S. Khan, M. M. Al-Gayyar, M. M. El-Shishtawy, G. I. Liou, Retinal microglial activation and inflammation induced by Amadori-glycated albumin in a rat model of diabetes. Diabetes 60, 1122-1133 (2011).
26. M. H. Tuszynski, J. D. Steeves, J. W. Fawcett, D. Lammertse, M. Kalichman, C. Rask, A. Curt, J. F. Ditunno, M. G. Fehlings, J. D. Guest, P. H. Ellaway, N. Kleitman, P. F. Bartlett, A. R. Blight, V. Dietz, B. H. Dobkin, R. Grossman, A. Privat; International Campaign for Cures of Spinal Cord Injury Paralysis, Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP Panel: Clinical trial inclusion/exclusion criteria and ethics. Spinal Cord 45, 222-231 (2007).
27. American Diabetes Association, Standards of medical care in diabetes - 2008. Diabetes Care 31 (Suppl. 1), S12-S54 (2008).
28. M. B. Bracken, M. J. Shepard, W. F. Collins, T. R. Holford, W. Young, D. S. Baskin, H. M. Eisenberg, E. Flamm, L. Leo-Summers, J. Maroon, L. F. Marshall, P. L. Perot Jr., J. Piepmeier, V. K. H. Sonntag, F. C. Wagner, J. E. Wilberger, H. R. Winn, A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study. N. Engl. J. Med. 322, 1405-1411 (1990).
29. A. Pajoohesh-Ganji, K. R. Byrnes, G. Fatemi, A. I. Faden, A combined scoring method to assess behavioral recovery after mouse spinal cord injury. Neurosci. Res. 67, 117-125 (2010).
30. G. C. Brown, Mechanisms of inflammatory neurodegeneration: iNOS and NADPH oxidase. Biochem. Soc. Trans. 35, 1119-1121 (2007).
31. T. Hayek, M. Kaplan, R. Kerry, M. Aviram, Macrophage NADPH oxidase activation, impaired cholesterol fluxes, and increased cholesterol biosynthesis in diabetic mice: A stimulatory role for D-glucose. Atherosclerosis 195, 277-286 (2007).
32. 2+-independent phospholipase A2 in neutrophils. J. Immunol. 184, 1507-1515 (2010).
33. S. H. Jackson, J. I. Gallin, S. M. Holland, The p47phox mouse knock-out model of chronic granulomatous disease. J. Exp. Med. 182, 751-758 (1995).
34. R. Schreck, P. Rieber, P. A. Baeuerle, Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1. EMBO J. 10, 2247-2258 (1991).
35. D. Kim, B. You, E. K. Jo, S. K. Han, M. I. Simon, S. J. Lee, NADPH oxidase 2-derived reactive oxygen species in spinal cord microglia contribute to peripheral nerve injury-induced neuropathic pain. Proc. Natl. Acad. Sci. U.S.A. 107, 14851-14856 (2010).
36. S. J. Campbell, P. M. Hughes, J. P. Iredale, D. C. Wilcockson, S. Waters, F. Docagne, V. H. Perry, D. C. Anthony, CINC-1 is an acute-phase protein induced by focal brain injury causing leukocyte mobilization and liver injury. FASEB J. 17, 1168-1170 (2003).
37. D. Gris, E. F. Hamilton, L. C. Weaver, The systemic inflammatory response after spinal cord injury damages lungs and kidneys. Exp. Neurol. 211, 259-270 (2008).
38. J. D. Kerby, R. L. Griffin, P. MacLennan, L. W. Rue III, Stress-induced hyperglycemia, not diabetic hyperglycemia, is associated with higher mortality in trauma. Ann. Surg. 256, 446-452 (2012).
39. R. Marfella, C. Di Filippo, M. Portoghese, F. Ferraraccio, M. R. Rizzo, M. Siniscalchi, E. Musacchio, M. D'Amico, F. Rossi, G. Paolisso, Tight glycemic control reduces heart inflammation and remodeling during acute myocardial infarction in hyperglycemic patients. J. Am. Coll. Cardiol. 53, 1425-1436 (2009).
40. E. Ritz, S. R. Orth, Nephropathy in patients with type 2 diabetes mellitus. N. Engl. J. Med. 341, 1127-1133 (1999).
41. N. T. Gentile, M. W. Seftchick, T. Huynh, L. K. Kruus, J. Gaughan, Decreased mortality by normalizing blood glucose after acute ischemic stroke. Acad. Emerg. Med. 13, 174-180 (2006).
42. A. M. Lam, H. R. Winn, B. F. Cullen, N. Sundling, Hyperglycemia and neurological outcome in patients with head injury. J. Neurosurg. 75, 545-551 (1991).
43. A. Fisette, M. Hassanain, P. Metrakos, S. A. Doi, A. Salman, T. Schricker, R. Lattermann, L. Wykes, E. Nitschmann, J. Smith, K. Cianflone, High-dose insulin therapy reduces postoperative liver dysfunction and complications in liver resection patients through reduced apoptosis and altered inflammation. J. Clin. Endocrinol. Metab. 97, 217-226 (2012).
44. G. van den Berghe, P. Wouters, F. Weekers, C. Verwaest, F. Bruyninckx, M. Schetz, D. Vlasselaers, P. Ferdinande, P. Lauwers, R. Bouillon, Intensive insulin therapy in critically ill patients. N. Engl. J. Med. 345, 1359-1367 (2001).
45. A. Balachandran, H. Guan, M. Sellan, S. van Uum, K. Yang, Insulin and dexamethasone dynamically regulate adipocyte 11β-hydroxysteroid dehydrogenase type 1. Endocrinology 149, 4069-4079 (2008).
46. E. Blasi, R. Barluzzi, V. Bocchini, R. Mazzolla, F. Bistoni, Immortalization of murine microglial cells by a v-raf/v-myc carrying retrovirus. J. Neuroimmunol. 27, 229-237 (1990).
47. G. Jalagadugula, G. Mao, G. Kaur, L. E. Goldfinger, D. N. Dhanasekaran, A. K. Rao, Regulation of platelet myosin light chain (MYL9) by RUNX1: Implications for thrombocytopenia and platelet dysfunction in RUNX1 haplodeficiency. Blood 116, 6037-6045 (2010).